Mr. Keshav Lahoti - Associate Equity Analyst, Angel Broking Ltd
"On a Consolidated basis for Q2FY21, HUL reported a 15.6% growth in revenue to ₹11,683 crore was above street expectation. Excluding the impact of GSK merger, organic growth was 3% only. Operating profit increased by 16.9% to ₹2,925 crore beat street expectation. Operating profit margin expanded by 20 basis point YoY to to 25%. PAT increased by 8.8% YoY to ₹1,974 cr was in line with street expectation. Home care segment and Beauty & Personal Care segment revenue declined marginally by 1.5% and 0.7% respectively. We believe discretionary spends are still not back to pre-covid levels so these segments have recorded a marginal drop in revenue. Although, mainly due to cost control management , all segment results improved compared to previous year. Company also declared an interim dividend ₹14/ share. From an investment perspective, we are bullish on HUL considering that discretionary spends are recovering back to pre-covid level, improving distribution and focus on premium products."
Shares of HINDUSTAN UNILEVER LTD. was last trading in BSE at Rs.2172.1 as compared to the previous close of Rs. 2178.8. The total number of shares traded during the day was 272156 in over 20222 trades.
The stock hit an intraday high of Rs. 2207 and intraday low of 2133. The net turnover during the day was Rs. 591372681.